L. reuteri DSM 17938/ATCC PTA
Dietary SupplementIngestion of active lozenge twice daily for 12 weeks
NCT Number: NCT02391532
The aim of this study is to investigate the effect of daily intake of the probiotic Lactobacillus Reuteri on the prevalence and counts of oral Candida in frail elderly living in nursery homes.
Looking for future studies?
Notify Me60 year and older
All sexes
Interventional
Not applicable
The aim of the present study was to investigate the effect of a twice daily intake of lozenges containing probiotic Lactobacillus reuteri on the prevalence and counts of oral Candida in senior residents living in nursery homes. The material consists of 215 elderly persons (range 60 to 102 years) living in 20 different nursery homes in the County of Kronoberg, situated in the southern parts of Sweden. The subjects were consecutively enrolled after informed consent consisting of verbal and written information directed to the individual as well as to their relatives. The study employed a double-blind randomized placebo-controlled design.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Ingestion of active lozenge twice daily for 12 weeks
Ingestion of placebo lozenge twice daily for 12 weeks
Time frame: Baseline and 12 weeks.
Saliva and plaque samples will be analyzed and data presented when all 215 participants have completed the intervention period.
Time frame: Baseline and 12 weeks.
Saliva and plaque samples will be analyzed and data presented when all 215 participants have completed the intervention period.
Time frame: Baseline and 12 weeks.
Secondary Outcome Measures will be measured before and after the intervention period.
Time frame: Baseline and 12 weeks.
Secondary Outcome Measures will be measured before and after the intervention period.
University of Copenhagen
Other
Effect of Probiotic Bacteria (L. Reuteri) on Oral Candida Counts in Frail Elderly
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT01322698
Bacterial Infections and Mycoses, Candidiasis
Nîmes, Gard, France
View Trial DetailsNCT02145832
Bacterial Infections and Mycoses, Candidiasis
Antwerp, Rocourt, Liège, Louvain, Namur, Belgium
View Trial DetailsNCT05707156
Aspergillosis, Bacterial Infections and Mycoses
Denver, Colorado, United States
View Trial DetailsNCT05235711
Bacterial Infections and Mycoses, Candidiasis
Rochester, Minnesota, United States
View Trial Details